Ozone Therapy and Coronavirus Disease of 2019 (COVID-19) Pneumonia

Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

Status: Completed

Conditions: COVID-19 Pneumonia

Study type: Observational

Funder types: Other

Identifiers

NCT04444531

COVID Networking group

Details and patient eligibility

About

The objective is to determine whether the use of ozone autohemotherapy is associated with a decrease in time to clinical improvement

Enrollment: 18 patients

Sex

Volunteers: No Healthy Volunteers

Inclusion criteria

• confirmed COVID-19 infection (diagnosed by nasopharyngeal swab performed on admission)
• severe pneumonia with baseline chest X-ray abnormalities;
• Oxygen saturation <94% on room air, and tachypnea with respiratory rate exceeding 30 per minute.
• Informed consent signed.

Exclusion criteria

• Not willing to participate in the study.

Trial design

18 participants in 2 patient groups

Ozone autohemotherapy plus standard treatment

Standard treatment alone